Bluejay Diagnostics Inc (BJDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -7,718 | -6,286 | -4,804 | -2,329 | -9,954 |
| Depreciation Amortization | 199 | 162 | 108 | 54 | 781 |
| Accounts payable and accrued liabilities | -346 | -175 | -1 | -220 | -236 |
| Other Working Capital | -633 | -577 | 156 | -38 | 667 |
| Other Operating Activity | 678 | 506 | 327 | 232 | 428 |
| Operating Cash Flow | $-7,821 | $-6,370 | $-4,215 | $-2,300 | $-8,314 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -307 | -306 | -305 | -35 | -704 |
| Investing Cash Flow | $-307 | $-306 | $-305 | $-35 | $-704 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | 2,000 | 2,000 | 2,000 | N/A | N/A |
| Debt Repayment | -4 | -3 | -2 | -1 | -5 |
| Common Stock Issued | 10,225 | 12,069 | 12,069 | 3,500 | 1,177 |
| Other Financing Activity | -2,000 | -3,844 | -3,697 | -711 | -61 |
| Financing Cash Flow | $10,221 | $10,222 | $10,370 | $2,788 | $1,112 |
| Beginning Cash Position | 2,209 | 2,209 | 2,209 | 2,209 | 10,115 |
| End Cash Position | 4,302 | 5,756 | 8,058 | 2,661 | 2,209 |
| Net Cash Flow | $2,093 | $3,547 | $5,850 | $453 | $-7,907 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,821 | -6,370 | -4,215 | -2,300 | -8,314 |
| Capital Expenditure | -307 | -306 | -305 | -35 | -704 |
| Free Cash Flow | -8,128 | -6,675 | -4,520 | -2,335 | -9,018 |